Skip to content
Resources > Reports

The Future of Generative AI in Business

The future of artificial intelligence (AI) is now.

No longer is AI and its various iterations sequestered to “high-tech” use cases, but instead, it’s being implemented into day-to-day business operations and decision-making. And while the excitement around generative AI (genAI) is rightly palpable amongst C-Suite executives, a number of important questions remain unanswered.

Which industries are ripe for disruption? What are the risks and unknowns of leaning on genAI for information? What societal behavior changes can be expected?

To gain answers to these pressing questions, we spoke with Eric Schmidt, Co-Founder of Schmidt Futures and Former CEO & Chairman of Google, and David Solomon, Chairman and CEO of Goldman Sachs. Learn what we can expect to see unfold with the rapid growth and implications of genAI in this informative Q&A.

The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient, and Goldman Sachs is not providing any financial, economic, legal, investment, accounting, or tax advice through this podcast or to its recipients.

Explore more

Inside Project Vault and the Global Hunt for Rare Earth Minerals

In this report, we leverage workflows from the AlphaSense platform to dig into Project Vault and assess its trajectory as judged by leading experts in the field.
Inside Project Vault and the Global Hunt for Rare Earth Minerals. Blue line art of a mining dump truck and rocks on a light blue, lined background.

The VC Playbook: How to Spot a Purple Cow in Crowded Pastures

In this playbook, we leverage insights from Harry Stebbings of 20VC to answer this question among others, including: What are the characteristics of successful early stage companies? Which unconventional criteria play an important role in securing deals?
Title slide for 'The Venture Capital Playbook: How to Spot a Purple Cow in Crowded Pastures,' featuring outlined illustrations of a purple cow and a white bull.

Execution in Focus: Tracking Key Healthcare and Biopharma Trends in 2026

This report tackles these issues and other key trends shaping the healthcare landscape in early 2026.
Title slide: Tracking Key Healthcare and Biopharma Trends in 2026 by Sara Mallatt and Sean Carmichael, featuring data graphs and medical icons.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.